NCT04573595View on ClinicalTrials.gov

Fresenius Noninvasive Blood Pressure Validation

NACompletedINTERVENTIONAL

Enrollment

159

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

December 4, 2020

Study Completion Date

December 4, 2020

Conditions

Blood Pressure

Interventions

DEVICE

Blood Pressure Measurement

The purpose of this study is to provide supporting documentation for Noninvasive blood pressure measurement accuracy claims for Fresenius 5008S BPM Module and Cuffs on the intended population(s). The same arm sequential method with dual observer auscultation will be used to collect data.

Trial Locations (1)

80027

Clinimark, Site ID#001, Louisville

All Listed Sponsors

lead

Fresenius Medical Care North America

INDUSTRY

NCT04573595 - Fresenius Noninvasive Blood Pressure Validation | Biotech Hunter | Biotech Hunter